Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Dec 20, 2020 10:57pm
116 Views
Post# 32150445

RE:RE:RE:RE:COVID19 virus is AIRBORNE - per my opinion

RE:RE:RE:RE:COVID19 virus is AIRBORNE - per my opinion
You or I don't set stock price. I can buy as much I can afford or sell but cannot manipulate the stock price. For now, my little money can buy me more shares compare to if I need to pay $1 or more. I am not saying anything of my own. We are calculating, according to as many tests collection sites are selling per month, at what price and profit margin. Comparing and calculating is part of the investment if you are not a penny pincher or a day trader. 
 
Most of us here at QSC doesn't go to other boards pumping QuestCap because we trust our investment. Most people who do not trust their investment usually go out looking for other people to buy so they can sell.  As I said before, I have no plan to sell QSC anytime soon. I think for me, the Medi-volve share price should be much better by the end of March-April. Medi-volve should have 200-500 testing centres by then and showing a lot of revenue. 
 
We can research then compare it with other companies. As we can see with the kind of revenue QuestCap is generating compare to others. The price we pay to buy QSC is less risky compare to others. QuestCap, generating $12 million in revenue per month with a market cap of $37 million. You can see QuestCap little risk and potential upside. 
 
All I did was compare both KNR and QSC. 
  • KNR generating $1 million a month with a market cap of $130 million
  • QSC generating $12 million a month with a market cap of $37 million
 
Anyone can see which one is riskier and which has a huge potential upside. For KNR to generate $12 a month, they need to sell 1200 bio cloud every month. Let alone QuestCap should be generating double the revenue by the mid to end of January compared to this coming weekend. Collection sites should 100 plus locations by the end of January compare to 45.
 
I do expect QuestCap should be able to ramp up quickly. They probably are learning more as they go. Now they should have more money, more experience and more staff to help them. I also think Medi-volve can attract more investors with $12 million in revenue per month. Management can spare more time taking and updating investors compare to money and expending. A startup is always hard once all setup it becomes easy to expand. 

RockThunder wrote: You know i realy like you Sarb99 ,,i m not bashing but all what you say about qsc versus knr ,,my big question is why are we at .24cent instead of 3.44 like knr then ,,and when we gone a hit 2$ and more


<< Previous
Bullboard Posts
Next >>